Plain-English translation of NCT06843356 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
This study doesn't follow the usual testing phases โ it may be an observational study or a different type of research.
This trial is testing whether an emergency procedure called endovascular therapy โ which uses a catheter to physically remove a blood clot or reopen a blocked artery โ works better than medication alone for people with a specific type of mild stroke caused by a blocked basilar artery. The blocked basilar artery is a major blood vessel in the brain, and this study focuses on patients whose symptoms are getting worse over time. Researchers want to know if combining this mechanical treatment with the best medical care available can help people recover better neurological function.
Strokes caused by a blocked basilar artery can be very serious, and patients whose symptoms get worse over the first few days face higher risks of permanent disability. While emergency endovascular therapy has helped some stroke patients, it's not yet clear whether this treatment helps people with mild symptoms who are getting progressively worse, especially when the procedure is done more than 24 hours after the stroke starts.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you qualify and enroll, you will be randomly assigned to one of two groups. Two-thirds of participants will receive the emergency catheter procedure (endovascular therapy) along with the best available medical care, while one-third will receive medication and supportive care alone. The study involves visits to the hospital for imaging scans and neurological exams to track how well you recover over time. Your participation will help doctors understand whether this emergency procedure can help people with this type of progressive stroke recover better.
AI-generated summary from trial data ยท Jun 7, 2026 ยท Not medical advice
China
Sponsor
First Affiliated Hospital of Wannan Medical College
Enrollment target
~159 participants
Started
June 2024
Primary completion
September 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in April 2025.
Reach out to the team running this trial. Response times vary โ some teams are faster than others.
Central contact
Xianjun Huang, PhD
First Affiliated Hospital of Wannan Medical College
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first โ no email needed to get started.